Dyspnea management in alpha-I antitrypsin deficiency: Effect of oxygen administration

Nursing Research

Volumn 49, Issue 6, 2000, Pages 333-338

  Knebel, Ann R ^a,c   Bentz, Ellen ^b   Barnes, Pauline ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b ALLEGHENY COLLEGE   (United States)

^c NATIONAL INSTITUTE OF NURSING RESEARCH   (United States)

Author keywords

Dyspnea; Emphysema; Oxygen inhalation therapy

Indexed keywords

ADULT; AGED; ALPHA 1 ANTITRYPSIN DEFICIENCY; ANALYSIS OF VARIANCE; ARTICLE; CLASSIFICATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DYSPNEA; FEMALE; HEART RATE; HUMAN; MALE; MIDDLE AGED; OXIMETRY; OXYGEN THERAPY; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; WALKING;

ADULT; AGED; ALPHA 1-ANTITRYPSIN DEFICIENCY; ANALYSIS OF VARIANCE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DYSPNEA; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; OXIMETRY; OXYGEN INHALATION THERAPY; PAIN MEASUREMENT; WALKING;

EID: 0034320147     PISSN: 00296562     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006199-200011000-00007     Document Type: Article

References (32)

1. Anonymous. (1987). Standardization of spirometry: 1987 update. Statement of the American Thoracic Society. American Review of Respiratory Disease, 136, 1286-1296.
2. Anonymous. (1989). Guidelines for the approach to the patient with severe hereditary alpha-1 antitrypsin deficiency. American Thoracic Society. American Review of Respiratory Disease, 140, 1494-1497.
3. Anonymous. (1997). Alpha 1-antitrypsin deficiency: Memorandum from a WHO meeting. Bulletin of the World Health Organization, 75(5), 397-415.
4. 1 antitrypsin deficiency. Annals of Allergy, 72, 105-122.
5. Butland, R. J., Pang, J., Gross, E. R., Woodcock, A. A., & Geddes, D. M. (1982). Two-, six-, and 12-minute walking tests in respiratory disease. British Medical Journal Clinical Research Edition, 284, 1607-1608.
6. Crapo, R. O., & Morris, A. H. (1981). Standardized single breath normal values for carbon monoxide diffusing capacity. American Review of Respiratory Disease, 123, 185-189.
7. Crapo, R. O., Morris, A, H., & Gradner, R. M. (1981). Reference spirometric values using techniques and equipment that meet ATS recommendations. American Review of Respiratory Disease, 123, 659-664.
8. Davidson, A. C., Leach, R., George, R. J., & Geddes, D. M. (1988). Supplemental oxygen and exercise ability in chronic obstructive airways disease. Thorax, 43, 965-971.
9. Dean, N. C., Brown, J. K., Himelman, R. B., Doherty, J. J., Gold, W. M., & Stulbarg, M. S. (1992). Oxygen may improve dyspnea and endurance in patients with chronic obstructive pulmonary disease and only mild hypoxemia. American Review of Respiratory Disease, 146, 941-945.
10. Geddes, D. M., & Beckles, M. A. (1995). Gene therapy for alpha-1 antitrypsin deficiency. Monaldi Archives for Chest Disease, 50, 388-393.
11. Gift, A., & Shepard, C. E. (1999). Fatigue and other symptoms in patients with chronic obstructive pulmonary disease. Do women and men differ? Journal of Obstetric, Gynecologic, and Neonatal Nursing, 28, 201-208.
12. Gosselink, R., Troosters, T., & Decramer, M. (1996). Peripheral muscle weakness contributes to exercise limitation in COPD. American Journal of Respiratory & Critical Care Medicine, 153, 976-980.
13. Guyatt, G. H., Pugsley, S. O., Sullivan, M. J., Thompson, P. J., Berman, L. B., Jones, N. L., Fallen, E. L., & Taylor, D. W. (1984). Effect of encouragement on walking test performance. Thorax, 39, 818-822.
14. Knebel, A. R., Leidy, N. K., & Sherman, S. (1998). When is the dyspnea worth it? Understanding functional performance in patients with alpha-1 antitrypsin deficiency. Image - The Journal of Nursing Scholarship, 30, 339-343.
15. Knebel, A. R., Leidy, N. K., & Sherman, S. (1999). Health related quality of life and disease severity in patients with alpha-1 antitrypsin deficiency. Quality of Life Research, 8, 385-391.
16. Larson, J. L., Covey, M., Vitalo, C., Alex, C., Patel, M., & Kim, M. (1996). Reliability and validity of the 12-minute distance walk in patients with chronic obstructive pulmonary disease. Nursing Research, 45, 203-210.
17. Leach, R. M., Davidson, A. C., Chinn, S., Twort, C. H., Cameron, I. R., & Bateman, N. T. (1992). Portable liquid oxygen and exercise ability in severe respiratory disability. Thorax, 47, 781-789.
18. Leidy, N. K., & Traver, G. A. (1995). Psychophysiologic factors contributing to functional performance in people with COPD: Are there gender differences? Research in Nursing and Health, 18, 535-546.
19. MacDonald, J. L., & Johnson, C. E. (1995). Pathophysiology and treatment of alpha-1 antitrypsin deficiency. American Journal of Health-System Pharmacy, 52, 481-489.
20. Mador, M. J., & Kufel, T. J. (1992). Reproducibility of visual analogue scale measurements if dyspnea in patients with chronic obstructive pulmonary disease. American Review of Respiratory Disease, 146, 82-87.
21. Mak, V. H., Bugler, J. R., Roberts, C. M., & Spiro, S. G. (1993). Effect of arterial oxygen desaturation on six minute walk distance, perceived effort, and perceived breathlessness in patients with airflow limitation. Thorax, 48, 33-38.
22. McCord, M., & Cronin-Stubbs, D. (1992). Operationalizing dyspnea: Focus on measurement. Heart and Lung, 21, 167-179.
23. McGavin, C. R., Gupta, S. P., & McHardy, G. J. (1976). Twelve-minute walking test for assessing ability in chronic bronchitis. British Medical Journal, 1, 822-823.
24. Nellcor. (1991). Operator's manual. Nellcor portable pulse oximeter, model N10 (p. 28). Hayward, CA: Nellcor Inc.
25. O'Donnell, D. E., Bain, D. J., & Webb, K. A. (1997). Factors contributing to relief of exertional breathlessness during hyperoxia in chronic airflow limitation. American Journal of Respiratory & Critical Care Medicine, 155, 530-535.
26. O'Donohue, W. J., Jr. (1997). Home oxygen therapy. Clinics in Chest Medicine, 18, 535-545.
27. Seersholm, N., Kok-Johnson, A., & Dirksen, A. (1994). Survival of patients with severe alpha-1 antitrypsin deficiency with special reference to non-index cases. Thorax, 94, 695-698.
28. Silverman, E. K., Chapman, H. A., Drazen, J. M., Weiss, S. T., Rosner, B., Campbell, E. J., O'Donnell, W. J., Reilly, J. J., Ginns, L., Mentzer, S., Waijn, J., & Speizer, F. E. (1998). Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. American Journal of Respiratory & Critical Care Medicine, 157, 1770-1778.
29. Stoller, J. K., Smith, P., Yang, P., & Spray, J. (1994). Physical and social impact of alpha-1 antitrypsin deficiency: Results of a survey. Cleveland Clinic Journal of Medicine, 61, 461-467.
30. Szaflarski, N. L., & Cohen, N. H. (1989). Use of pulse oximetry in critically ill adults. Heart & Lung, 18, 444-453.
31. van Steenbergen, W. (1993). Alpha-1 antitrypsin deficiency: An overview. Acta Clinica Belgica, 48(3), 171-189.
32. Wijkstra, P. J., Tenvergert, E. M., van der Mark, T. W., Postma, D. S., Van Altena, R., Kraan, J., & Koeter, G. H. (1994). Relation of lung function, ,maximal inspiratory pressure, dyspnoea, and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease. Thorax, 49, 468-472.